World Health Organization. Global genomic surveillance strategy for pathogens with pandemic and epidemic potential 2022–2032. WHO 2022 (2022).
Gardy, J. L. & Loman, N. J. Towards a genomics-informed, real-time, global pathogen surveillance system. Nat. Rev. Genet. 19, 9–20 (2018).
Black, A., MacCannell, D. R., Sibley, T. R. & Bedford, T. Ten recommendations for supporting open pathogen genomic analysis in public health. Nat. Med. 26, 832–841 (2020).
Chen, Z. et al. Global landscape of SARS-CoV-2 genomic surveillance and data sharing. Nat. Genet. 54, 499–507 (2022).
Inzaule, S. C. et al. Genomic-informed pathogen surveillance in Africa: Opportunities and challenges. Lancet Infect. Dis. 21(9), e281–e289 (2021).
WHO Guiding principles for pathogen genome data sharing. WHO (2022).
Tosta, S. et al. Global SARS-CoV-2 genomic surveillance: What we have learned (so far). Infect. Genet. Evol. 108, 105405 (2023).
Brito, A. et al. Global disparities in SARS-CoV-2 genomic surveillance. Nat. Comm. 13(1), 7003 (2022).
Lenharo, M. ‘Pandemic treaty’: Nations wrestle with sharing virus data. Nature 618, 896–897 (2023).
Enserink, M. & Cohen, J. Control issues. Science 380(6643), 332–339 (2023).
Halabi, S., Wilder, R., Gostin, L. O. & Hurtado, M. L. Sharing pathogen genomic sequence data – Toward effective pandemic prevention, preparedness, and response. New Engl. J. Med. 388, 2401–2404 (2023).
Field, E., Strathearn, M., Boyd-Skinner, C. & Dyda, A. Usefulness of linked data for infectious disease events: A systematic review. Epidemiol. Infect. 151, e46 (2023).
Sintchenko, V. & Coiera, E. The case for including microbial sequences in the electronic health record. Nat. Med. 29(1), 22–25 (2023).
Ladner, J. T. & Sahl, J. W. Towards a post-pandemic future for global pathogen genome sequencing. PLoS Biol. 21(8), e3002225 (2023).
Badal, K., Lee, C. M. & Esserman, L. J. Guiding principles for the responsible development of artificial intelligence tools for healthcare. Comm. Med. 3, 47 (2023).
Liang, W. et al. Advances, challenges and opportunities in creating data for trustworthy AI. Nat. Machine Intell. 4, 669–677 (2022).
Walton, M. G., Cubillejo, I., Nag, D. & Withey, J. H. Advances in cholera research: from molecular biology to public health initiatives. Front. Microbiol. 14, 1178538 (2023).
Hu, D. et al. Origins of the current seventh cholera pandemic. Proc. Natl. Acd. Sci. USA 113(48), E7730–E7739 (2016).
Griffiths, E. J. et al. Future-proofing and maximizing the utility of metadata: the PHA4GE SARS-CoV-2 contextual data specification package. Gigascience. 11, giac003 (2022).
Brown, B. et al. An economic evaluation of the whole genome sequencing source tracking program in the U.S. PLoS One. 16(10), e0258262 (2021).
Ending Cholera: A global roadmap to 2030. Global Task Force on Cholera Control, World Health Organization, (https://www.gtfcc.org/wp-content/uploads/2019/10/gtfcc-ending-cholera-a-global-roadmap-to-2030.pdf) (2017).
Spiekermann, M. Data marketplaces: Trends and monetisation of data goods. Intereconom. 54(4), 208–216 (2019).
Sielemann, K., Hafner, A. & Pucker, B. The reuse of public datasets in the life sciences: Potential risks and rewards. Peer J. 8, e9954 (2020).
Cheung, S. Disambiguating the benefits and risks from public health data in the digital economy. Big Data & Society 7, 1 (2020).
Ling-Hu, T. et al. Challenges and opportunities for global genomic surveillance strategies in the COVID-19 era. Viruses 14(11), 2532 (2022).
Mahanta, U., Saberwal, G. & Sharma, G. Are countries becoming better at SARS-CoV-2 genomics surveillance? Front. Public Health. 10, 887955 (2022).
Kabir, M., Imam, R., Farzana, Z. & Hossain, C. F. Complete genome sequence of the pandrug-resistant Vibrio cholerae strain KBR06 isolated from a cholera patient in Bangladesh. Microbiol. Res. Announc. 12(12), e0057723 (2023).
Holden, N. J. Data sharing considerations to maximize the use of pathogen biological and genomics resources data for public health. J. Appl. Microbiol. 135(9), lxae204 (2024).
Reichman, J., Uhlir, P., Dedeurwaerdere, T. Governing digitally integrated genetic resources, data and literature: Global intellectual property strategies for a redesigned microbial research commons. Cambridge University Press (2016).
GenEpiO Consortium. Genomic Epidemiology Ontology. https://geneepio.org (2025).
Timme, R. E. et al. Optimizing open data to support one health: best practices to ensure interoperability of genomic data from bacterial pathogens. One Health Outlook 2, 1–11 (2020).
Gill, I. S. et al. The DataHarmonizer: A tool for faster data harmonization, validation, aggregation and analysis of pathogen genomics contextual information. Microb. Genom. 9(1), mgen000908 (2023).
Pettengill, J. B. et al. Interpretive labor and the bane of nonstandardized metadata in public health surveillance and food safety. Clin. Infect. Dis. 73(8), 1537–1539 (2021).
Jolley, K. A., Bray, J. E. & Maiden, M. C. J. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 3, 124 (2018).
Sintchenko, V., Sim, E. & Suster, C. Estimating the deferred value of pathogen genomic data for secondary use (Version 2). Zenodo https://doi.org/10.5281/zenodo.15192410 (2025).
NCBI Reference Sequence https://identifiers.org/refseq.gcf:GCF_008369605.1 (2019).
Bogaerts, B. et al. Evaluation of WGS performance for bacterial pathogen characterization with the Illumina technology optimized for time-critical situations. Microb. Genom. 7(11), 000699 (2021).
Wible, J. R. The economics of science: Methodology and epistemology as if economics really mattered (Routledge, 1998).
Aggarwal, A. et al. Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia. Nat. Microbiol. 7, 896–908 (2022).
Rockett, R. J. et al. Genomic surveillance enables suitability assessment of Salmonella gene targets used for culture-independent diagnostic testing. J. Clin. Microbiol. 58(9), e00038-20 (2020).
Rockett, R. J. et al. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modelling. Nat. Med. 26(9), 1398–1404 (2020).
Mason, L. et al. The evolution and international spread of extensively drug resistant Shigella sonnei. Nat. Comm. 14(1), 1983 (2023).
Shuaib, Y. A. et al. Origin and global expansion of Mycobacterium tuberculosis complex lineage 3. Genes 13(6), 990 (2022).
Walker, J. et al. Assessing the global risk of typhoid outbreaks caused by extensively drug resistant Salmonella Typhi. Nat. Comm. 14, 6502 (2023).
Chen, Y., Liu, Q., Takiff, H. E. & Gao, Q. Comprehensive genomic analysis of Mycobacterium tuberculosis reveals limited impact of high-fitness genotypes on MDR-TB transmission. J. Infect. 85(1), 49–56 (2022).
Gangavarapu, K. et al. Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations. Nat. Meth. 20, 512–522 (2023).
Payne, M. et al. Multilevel genome typing: Genomics-guided scalable resolution typing of microbial pathogens. EuroSurveillance 2020 25(20), 1900519 (2020).
Suster, C. J. E. et al. Guiding the design of SARS-CoV-2 genomic surveillance by estimating the resolution of outbreak detection. Front. Public Health. 10, 1004201 (2022).
Duchene, S. et al. Assessment of Coronavirus Disease 2019 intervention strategies in the Nordic Countries using genomic epidemiology. Open Forum Infect. Dis. 9(3), ofab665 (2022).
Arnott, A. et al. Documenting elimination of co-circulating COVID-19 clusters using genomics in New South Wales, Australia. BMC Res. Notes 14(1), 415 (2021).
Bortolaia, V. et al. ResFinder 4.0 for predictions of phenotypes from genotypes. J. Antimicrob. Chemother. 75(12), 3491–3500 (2020).
Walker, T. M. et al. The CRyPTIC Consortium, The Seq&Treat Consortium, Crook DW, Ismail N and Rodwell TC. The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: A new global standard for molecular diagnostics. Lancet Microbe 3(4), e265–e273 (2021).
Fong, W. et al. SABRes: in silico detection of drug resistance conferring mutations in subpopulations of SARS-CoV-2 genomes. BMC Infect. Dis. 23(1), 303 (2023).
Ren, Y. et al. Prediction of antimicrobial resistance based on whole-genome sequencing and machine learning. Bioinform. 38(2), 325–334 (2022).
Green, A. G. et al. A convolutional neural network highlights mutations relevant to antimicrobial resistance in Mycobacterium tuberculosis. Nat. Comm. 13(1), 3817 (2022).
Ali, M., Nelson, A. R., Lopez, A. L. & Sack, D. A. Updated global burden of cholera in endemic countries. PLoS Negl. Trop. Dis. 9(6), e0003832 (2015).
